A prospective, multicentre trial of high-dose methotrexate/doxorubicin or cisplatin/doxorubicin for children and young adults with osteosarcoma - decision making analysisb

被引：0
|
作者：
Wozniak, W. [1 ]
Chybicka, A. [2 ]
Kowalczyk, J. [3 ]
Wysocki, M. [4 ]
Korzon, M. [5 ]
Krawczuk-Rybak, M. [6 ]
Rychlowska-Pruszynska, M. [1 ]
Szamotulska, K. [7 ]
Lugowska, I. [1 ]
机构：
[1] Inst Mother & Child Hlth, Dept Paediat Oncol Surg, Warsaw, Poland
[2] Wroclaw Med Univ, Dept Pediat Bone Marrow Transplantat Oncol & Hema, Wroclaw, Poland
[3] Med Univ Lublin, Dept Pediat Hematol & Oncol, Lublin, Poland
[4] Med Univ Bydgoszcz, Dept Pediat Hematol & Oncol, Bydgoszcz, Poland
[5] Med Univ Gdansk, Clin Pediat Pediat Gastroenterol & Oncol, Gdansk, Poland
[6] Med Univ Bialystok, Dept Pediat Hematol & Oncol, Bialystok, Poland
[7] Inst Mother & Child Hlth, Dept Epidemiol, Warsaw, Poland
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)70766-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [31] CHEMOTHERAPY OF THE ADVANCED PANCREATIC-CANCER WITH 5-FLUOROURACIL, DOXORUBICIN AND HIGH-DOSE METHOTREXATE
    SCHEITHAUER, W
    LUDWIG, H
    ZIELINSKI, C
    FUNOVICS, J
    KNOFLACH, P
    MULLER, C
    GRABNER, G
    LEBER MAGEN DARM, 1988, 18 (03) : 149 - &
  • [32] Prospective evaluation of renal function in pediatric and adult patients treated with high-dose ifosfamide, cisplatin and high-dose methotrexate
    Ferrari, S
    Pieretti, F
    Verri, E
    Tolentinis, L
    Cesari, M
    Versari, M
    Zolezzi, C
    Lamanna, G
    Bacci, G
    ANTI-CANCER DRUGS, 2005, 16 (07) : 733 - 738
  • [33] Efficacy of dose-intensified MEC (methotrexate, epirubicin and cisplatin) chemotherapy for advanced urothelial carcinoma: A prospective randomized trial comparing MEC and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin)
    Kuroda, M
    Kotake, T
    Akaza, H
    Hinotsu, S
    Kakizoe, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (08) : 497 - 501
  • [34] Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide
    Bacci, G
    Briccoli, A
    Rocca, M
    Ferrari, S
    Donati, D
    Longhi, A
    Bertoni, F
    Bacchini, P
    Giacomini, S
    Forni, C
    Manfrini, M
    Galletti, S
    ANNALS OF ONCOLOGY, 2003, 14 (07) : 1126 - 1134
  • [35] Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate as neoadjuvant therapy for osteosarcoma: A single-arm, exploratory phase II trial
    Tang, Qinglian
    Zhu, Xiaojun
    Song, Guohui
    Lu, Jinchang
    Wu, Hao
    Xu, Huaiyuan
    Zhang, Xin-Ke
    Ai, Fei
    Zhang, Yingchun
    Wang, Jin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] LOW-DOSE CONTINUOUS-INFUSION DOXORUBICIN IN CHILDREN AND YOUNG-ADULTS
    KYNASTON, JA
    PEARSON, ADJ
    KERNAHAN, J
    LUCRAFT, H
    BARSTOW, D
    THOMPSON, A
    CRAFT, AW
    MEDICAL AND PEDIATRIC ONCOLOGY, 1993, 21 (07): : 494 - 498
  • [37] Nonmetastatic osteosarcoma of the extremity: Results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intraarterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor response
    Ferrari, S
    Mercuri, M
    Picci, P
    Bertoni, F
    del Prever, AB
    Tienghi, A
    Mancini, A
    Longhi, A
    Rimondini, S
    Donati, D
    Manfrini, M
    Ruggieri, P
    Biagini, R
    Bacci, G
    TUMORI, 1999, 85 (06) : 458 - 464
  • [38] SEQUENTIAL HIGH-DOSE METHOTREXATE, 5-FLUOROURACIL, AND DOXORUBICIN FOR TREATMENT OF ADVANCED PANCREATIC-CANCER
    SCHEITHAUER, W
    FUNOVICS, J
    MUELLER, C
    LUDWIG, H
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (02) : 132 - 133
  • [39] HIGH-DOSE, SHORT-DURATION CISPLATIN DOXORUBICIN COMBINATION CHEMOTHERAPY FOR ADVANCED OVARIAN EPITHELIAL CANCER
    HUNTER, RE
    GRIFFIN, TW
    STEVENS, S
    ROMAN, LD
    BOKHARI, F
    REALE, FR
    TAK, WK
    FITZGERALD, TJ
    DILLON, MB
    ROSE, PG
    CANCER, 1991, 68 (09) : 1890 - 1894
  • [40] HIGH-DOSE INTENSITY, CIRCADIAN-TIMED DOXORUBICIN AND CISPLATIN ADJUVANT CHEMOTHERAPY FOR BLADDER-CANCER
    HRUSHESKY, WJM
    ROEMELING, RV
    WOOD, PA
    LANGEVIN, TR
    LANGE, P
    FRALEY, E
    CANCER TREATMENT REPORTS, 1987, 71 (10): : 915 - 919
12345